ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

“Action Steps” Listed For Prostate Research In National Blueprint

January 16, 1998

In Brief: US Pharmacopeia Names Advisory Panel For Hematologic And Oncological Disease

May 31, 1996

Mytomycin C, RT Improve Head & Neck Results, Sartorelli Reports; Other AACR, ASCO Lectures

June 5, 1987

Grant, contract Awards Held Up By Impasse On Appropriations

October 14, 1977

(8-page issue).

January 31, 2003

New Cooperative Group Funded

September 30, 1977